The effect of a geriatric evaluation on treatment decisions and outcome for older cancer patients–a systematic review

ME Hamaker, M Te Molder, N Thielen… - Journal of geriatric …, 2018 - Elsevier
Aim The aim of this systematic review is to summarise all available data on the effect of a
geriatric evaluation on the multidisciplinary treatment of older cancer patients, focussing on …

Geriatric assessment and management in cancer

S Rostoft, A O'Donovan, P Soubeyran… - Journal of Clinical …, 2021 - ascopubs.org
As the majority of patients with cancer are older than 65 years, most medical, surgical, and
radiation oncologists treat a large number of older adults in their clinical practice. Older …

Detection of solid tumor molecular residual disease (MRD) using circulating tumor DNA (ctDNA)

RI Chin, K Chen, A Usmani, C Chua, PK Harris… - Molecular diagnosis & …, 2019 - Springer
Circulating tumor DNA (ctDNA) is a component of cell-free DNA that is shed by malignant
tumors into the bloodstream and other bodily fluids. Levels of ctDNA are typically low …

The effect of geriatric intervention in frail older patients receiving chemotherapy for colorectal cancer: a randomised trial (GERICO)

CM Lund, KK Vistisen, AP Olsen, P Bardal… - British journal of …, 2021 - nature.com
Background Older patients with colorectal cancer (CRC) experience chemotherapy dose
reductions or discontinuation. Comprehensive geriatric assessment (CGA) predicts survival …

The effect of a geriatric evaluation on treatment decisions for older cancer patients–a systematic review

ME Hamaker, AH Schiphorst… - Acta …, 2014 - Taylor & Francis
Aim. The aim of this systematic review is to summarise all available data on the effect of a
geriatric evaluation on the multidisciplinary treatment of older cancer patients, focussing on …

[HTML][HTML] Functional status decline in older patients with breast and colorectal cancer after cancer treatment: a prospective cohort study

D van Abbema, A van Vuuren… - Journal of geriatric …, 2017 - Elsevier
Objectives The aim of the present study was to disentangle the impact of age and that of
cancer diagnosis and treatment on functional status (FS) decline in older patients with …

[HTML][HTML] Patient-and tumor-related predictors of chemotherapy intolerance in older patients with cancer: a systematic review

DL van Abbema, M van den Akker… - Journal of geriatric …, 2019 - Elsevier
Objective The aim of this systematic review was to investigate patient-related factors (eg
depressive symptoms, cognition, mobility, activities of daily living (ADL)) as well as tumor …

Older cancer patients' information and communication needs: what they want is what they get?

JCM van Weert, S Bolle, S van Dulmen… - Patient education and …, 2013 - Elsevier
Objective To evaluate what information and communication aspects older cancer patients
(≥ 65) consider important in preparing for chemotherapy treatment (CT), the extent to which …

Prognostic value of polycomb proteins EZH2, BMI1 and SUZ12 and histone modification H3K27me3 in colorectal cancer

A Benard, IJ Goossens-Beumer, AQ van Hoesel… - PloS one, 2014 - journals.plos.org
Numerous changes in epigenetic mechanisms have been described in various types of
tumors. In search for new biomarkers, we investigated the expression of Polycomb-group …

[HTML][HTML] Systematic review: Incidence, risk factors, survival and treatment of bone metastases from colorectal cancer

TD Christensen, SG Jensen, FO Larsen… - Journal of bone …, 2018 - Elsevier
Background Bones are not considered a frequent metastatic site in patients with colorectal
cancer (CRC). The purpose of the present study was to determine the incidence of bone …